Fortitude Family Office’s Avita Medical RCEL Stock Holding History

Fortitude Family Office’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285	Buy	+69	New	+$298	﹤0.01%	2065

Other funds holding RCEL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Fortitude Family Office's RCEL Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Avita Medical (RCEL) in Q2 2026: 69 shares worth $285. The stake represents ﹤0.01% of the portfolio and ranks #2065 among its holdings.

11 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Fortitude Family Office held 69 shares of Avita Medical worth $285 as of Q2 2026.
Avita Medical was a new Fortitude Family Office position in Q2 2026.
Avita Medical made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2065 holding.
11 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.